Thanh bên bài viết

PDF (English)
Đã xuất bản: 2024-11-28
Số lượt xem tóm tắt: 0
Số lượt xem PDF (English): 0
DOI: https://doi.org/10.52852/tcncyh.v184i11E15.2501
Số xuất bản
Tập 184 Số 11E15 (2024)
Chuyên mục
Các bài báo
Cách trích dẫn
Cuc, P. H. ., Lan, H. T. N. ., Que, T. T. ., Hien, T. ., & Son, N. B. . (2024). Value of Non-invasive Prenatal Test (NIPT) for comprehensive fetal aneuploidies screening. Tạp Chí Nghiên cứu Y học, 184(11E15), 52-61. https://doi.org/10.52852/tcncyh.v184i11E15.2501

Value of Non-invasive Prenatal Test (NIPT) for comprehensive fetal aneuploidies screening

Phan Hoang Cuc, Hoang Thi Ngoc Lan, Trinh Thi Que, Tran Hien, Nguyen Ba Son

Nội dung chính của bài viết

Tóm tắt

The expanded NIPT for screening all fetal chromosomal aneuploidies has been widely used in clinical practice. The study was conducted on 6,104 pregnant women performing this test at Medlatec General Hospital to evaluate the values of NIPT. Sensitivity and negative predictive value reach 100%, and specificity reaches over 99.8%. The positive predictive values for trisomy 21, trisomy 18, trisomy 13, sex chromosome aneuploidies, and rare chromosome aneuploidies are 88.89%, 62.50%; 50.00%; 36.67%, and 0%, respectively. Among rare chromosome aneuploidies, trisomy 2, 4, 9, 15, 16, and 22 are reported to have adverse outcomes, while trisomy 3, 7, 8, and 20 reported no cases. Therefore, the NIPT can potentially predict adverse pregnancy outcomes for rare chromosome aneuploidies.

Chi tiết bài viết

Từ khóa

Non-invasive Prenatal Testing, NIPT, NIPS, prenatal screening

Tài liệu tham khảo

1. Wellesley D, Dolk H, Boyd PA, et al. Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe. Eur J Hum Genet. 2012;20(5):521-526. doi:10.1038/ejhg.2011.246
2. Grati FR, Ferreira J, Benn P, et al. Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA. Genet Med. 2020;22(2):309-316. doi:10.1038/s41436-019-0630-y
3. Grau Madsen S, Uldbjerg N, Sunde L, et al. Prognosis for pregnancies with trisomy 16 confined to the placenta: A Danish cohort study. Prenat Diagn. 2018;38(13):1103-1110. doi:10.1002/pd.5370
4. Qi Y, Yang J, Hou Y, et al. The significance of trisomy 7 mosaicism in noninvasive prenatal screening. Hum Genomics. 2019;13(1):18. doi:10.1186/s40246-019-0201-y
5. Zhu X, Lam DYM, Chau MHK, et al. Clinical Significance of Non-Invasive Prenatal Screening for Trisomy 7: Cohort Study and Literature Review. Genes. 2020;12(1):11. doi:10.3390/genes12010011
6. Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372(17):1589-1597. doi:10.1056/NEJMoa1407349
7. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics, Committee on Genetics, Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020;136(4):e48-e69. doi:10.1097/AOG.0000000000004084
8. Jayashankar SS, Nasaruddin ML, Hassan MF, et al. Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions. Diagnostics. 2023;13(15):2570. doi:10.3390/diagnostics13152570
9. Pescia G, Guex N, Iseli C, et al. Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive cases. Genet Med. 2017;19(2):169-175. doi:10.1038/gim.2016.72
10. Liu S, Yang F, Chang Q, et al. Positive predictive value estimates for noninvasive prenatal testing from data of a prenatal diagnosis laboratory and literature review. Mol Cytogenet. 2022;15:29. doi:10.1186/s13039-022-00607-z
11. Liang D, Lin Y, Qiao F, et al. Perinatal outcomes following cell-free DNA screening in >32 000 women: Clinical follow-up data from a single tertiary center. Prenat Diagn. 2018;38(10):755-764. doi:10.1002/pd.5328
12. Lu W, Huang T, Wang XR, et al. Next-generation sequencing: a follow-up of 36,913 singleton pregnancies with noninvasive prenatal testing in central China. J Assist Reprod Genet. 2020;37(12):3143-3150. doi:10.1007/s10815-020-01977-2
13. Gu Z, Du M, Xu T, et al. Study on the Clinical Value of Noninvasive Prenatal Testing in Screening the Chromosomal Abnormalities of the Fetus in the Elderly Pregnant Women. Comput Math Methods Med. 2022;2022:2977128. doi:10.1155/2022/2977128
14. Zheng Y, Li J, Zhang J, et al. The accuracy and feasibility of noninvasive prenatal testing in a consecutive series of 20,626 pregnancies with different clinical characteristics. J Clin Lab Anal. 2022;36(10):e24660. doi:10.1002/jcla.24660
15. Porreco RP, Garite TJ, Maurel K, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol. 2014;211(4):365.e1-12. doi:10.1016/j.ajog.2014.03.042
16. Deng C, Zhu Q, Liu S, et al. Clinical application of noninvasive prenatal screening for sex chromosome aneuploidies in 50,301 pregnancies: initial experience in a Chinese hospital. Sci Rep. 2019;9(1):7767. doi:10.1038/s41598-019-44018-4
17. Zhang M, Tang J, Li J, et al. Value of noninvasive prenatal testing in the detection of rare fetal autosomal abnormalities. Eur J Obstet Gynecol Reprod Biol. 2023;284:5-11. doi:10.1016/j.ejogrb.2023.03.002
18. Zhu X, Chen M, Wang H, et al. Clinical utility of expanded non-invasive prenatal screening and chromosomal microarray analysis in high-risk pregnancy. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2021;57(3):459-465. doi:10.1002/uog.22021
19. Hu T, Wang J, Zhu Q, et al. Clinical experience of noninvasive prenatal testing for rare chromosome abnormalities in singleton pregnancies. Front Genet. 2022;13. June 19, 2023. https://www.frontiersin.org/articles/10.3389/fgene.2022.955694